KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 154 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $11,053,000 | -66.4% | 3,140,071 | -4.6% | 0.26% | -62.1% |
Q2 2015 | $32,851,000 | -21.5% | 3,291,711 | +0.1% | 0.70% | -25.7% |
Q1 2015 | $41,841,000 | -9.0% | 3,286,844 | +1.2% | 0.94% | -14.4% |
Q4 2014 | $45,959,000 | +2.4% | 3,247,990 | -0.5% | 1.10% | -6.3% |
Q3 2014 | $44,874,000 | +40.2% | 3,263,528 | +56.8% | 1.17% | +53.7% |
Q2 2014 | $32,012,000 | -9.1% | 2,081,792 | +0.7% | 0.76% | -14.0% |
Q1 2014 | $35,223,000 | – | 2,067,053 | – | 0.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management, LLC | 700,273 | $10,770,000 | 5.76% |
HARVEY CAPITAL MANAGEMENT INC | 932,400 | $14,340,000 | 5.13% |
Camber Capital Management LP | 3,000,000 | $46,140,000 | 3.02% |
Baupost Group | 10,539,986 | $162,105,000 | 2.64% |
SECTORAL ASSET MANAGEMENT INC | 3,741,656 | $57,547,000 | 2.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,884,409 | $59,742,000 | 2.40% |
Knoll Capital Management, LLC | 200,000 | $3,076,000 | 1.37% |
DAFNA Capital Management LLC | 92,400 | $1,421,000 | 1.35% |
NORTHPOINTE CAPITAL LLC | 892,011 | $13,719,000 | 1.32% |
Rhenman & Partners Asset Management AB | 240,000 | $3,691,000 | 1.10% |